Related references
Note: Only part of the references are listed.HAE-AS: A Specific Disease Activity Scale for Hereditary Angioedema With C1-Inhibitor Deficiency
M. J. Forjaz et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2021)
Informed decision-making in hereditary angioedema prophylaxis
Autumn Ford Burnette
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
Anna Valerieva et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema
Karsten Weller et al.
ALLERGY (2020)
Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene
Konrad Bork et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Hereditary Angioedema
Paula J. Busse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema Control
Karsten Weller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence
Konrad Bork et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Shared decision making for the allergist
Michael S. Blaiss et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
Timothy Craig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Hereditary angioedema: examining the landscape of therapies and preclinical therapeutic targets
Henriette Farkas
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
M. Riedl et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients
Kanokvalai Kulthanan et al.
BIOMED RESEARCH INTERNATIONAL (2019)
The International/Canadian Hereditary Angioedema Guideline
Stephen Betschel et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2019)
Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States
Paula J. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
The international WAO/EAACI guideline for the management of hereditary angioedemaThe 2017 revision and update
M. Maurer et al.
ALLERGY (2018)
Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency
Timothy Craig et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
The use of tranexamic acid for on-demand and prophylactic treatment of hereditary angioedema-A systematic review
Takahiko Horiuchi et al.
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY (2018)
Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII)
K. Bork et al.
ALLERGY (2017)
Emerging Therapies in Hereditary Angioedema
Meng Chen et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Burden of Illness and Quality-of-Life Measures in Angioedema Conditions
Teresa Caballero et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Hereditary Angioedema with Normal C1 Inhibitor Update on Evaluation and Treatment
Markus Magerl et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
H. Longhurst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.
Anette Bygum et al.
FRONTIERS IN MEDICINE (2017)
Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36
Nina Lakhani Jindal et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2017)
Implementing shared decision-making: consider all the consequences
Glyn Elwyn et al.
IMPLEMENTATION SCIENCE (2016)
The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference
K. Weller et al.
ALLERGY (2016)
Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL
Nieves Prior et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)
Current state of hereditary angioedema management: A patient survey
Aleena Banerji et al.
ALLERGY AND ASTHMA PROCEEDINGS (2015)
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
Ivan R. Diamond et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor Deficiency
Bruce L. Zuraw et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2013)
Development and construct validation of the angioedema quality of life questionnaire
K. Weller et al.
ALLERGY (2012)
Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project
Nieves Prior et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2012)
Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency
Konrad Bork et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
TREATMENT OF HEREDITARY ANGIONEUROTIC OEDEMA WITH TRANEXAMIC ACID
G. Blohmé
ACTA MEDICA SCANDINAVICA (2010)
Share Paper
